These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28031538)

  • 1. Variants in microRNA genes in familial papillary thyroid carcinoma.
    Tomsic J; Fultz R; Liyanarachchi S; Genutis LK; Wang Y; Li W; Volinia S; Jazdzewski K; He H; Wakely PE; Senter L; de la Chapelle A
    Oncotarget; 2017 Jan; 8(4):6475-6482. PubMed ID: 28031538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.
    Geraldo MV; Nakaya HI; Kimura ET
    Oncotarget; 2017 Feb; 8(6):9597-9607. PubMed ID: 28030816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
    Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
    Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.
    Minna E; Romeo P; Dugo M; De Cecco L; Todoerti K; Pilotti S; Perrone F; Seregni E; Agnelli L; Neri A; Greco A; Borrello MG
    Oncotarget; 2016 Mar; 7(11):12731-47. PubMed ID: 26871295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 6. BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases.
    Zarkesh M; Zadeh-Vakili A; Akbarzadeh M; Nozhat Z; Fanaei SA; Hedayati M; Azizi F
    Life Sci; 2019 Apr; 223():166-173. PubMed ID: 30890403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer.
    Li D; Jian W; Wei C; Song H; Gu Y; Luo Y; Fang L
    Int J Clin Exp Pathol; 2014; 7(11):7672-80. PubMed ID: 25550803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
    Zhang M; Wu W; Gao M; Fei Z
    Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.
    Lee JC; Zhao JT; Clifton-Bligh RJ; Gill A; Gundara JS; Ip JC; Glover A; Sywak MS; Delbridge LW; Robinson BG; Sidhu SB
    Cancer; 2013 Dec; 119(24):4358-65. PubMed ID: 24301304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate microRNA expression profile in Graves' disease falls between that of normal thyroid tissue and papillary thyroid carcinoma.
    Pohl M; Grabellus F; Worm K; Arnold G; Walz M; Schmid KW; Sheu-Grabellus SY
    J Clin Pathol; 2017 Jan; 70(1):33-39. PubMed ID: 27371612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the BRAFV600E mutation.
    Huang Y; Liao D; Pan L; Ye R; Li X; Wang S; Ye C; Chen L
    Eur J Endocrinol; 2013 May; 168(5):675-81. PubMed ID: 23416953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
    Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC).
    Jazdzewski K; Boguslawska J; Jendrzejewski J; Liyanarachchi S; Pachucki J; Wardyn KA; Nauman A; de la Chapelle A
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E546-53. PubMed ID: 21159845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma.
    Qiu Z; Li H; Wang J; Sun C
    Oncol Rep; 2017 Nov; 38(5):2735-2740. PubMed ID: 29048684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma-Derived miRNA-222 as a Candidate Marker for Papillary Thyroid Cancer.
    Kondrotienė A; Daukša A; Pamedytytė D; Kazokaitė M; Žvirblienė A; Daukšienė D; Simanavičienė V; Klimaitė R; Golubickaitė I; Stakaitis R; Šarauskas V; Verkauskienė R; Žilaitienė B
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of miR‑486‑5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing.
    Wen DY; Pan DH; Lin P; Mo QY; Wei YP; Luo YH; Chen G; He Y; Chen JQ; Yang H
    Mol Med Rep; 2018 Sep; 18(3):2631-2642. PubMed ID: 30015845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of MiR-431 expression associated with lymph node metastasis and promotes cell invasion in papillary thyroid carcinoma.
    Liu Y; Li L; Liu Z; Yuan Q; Lu X
    Cancer Biomark; 2018; 22(4):727-732. PubMed ID: 29945344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family of microRNA-146 Regulates RARβ in Papillary Thyroid Carcinoma.
    Czajka AA; Wójcicka A; Kubiak A; Kotlarek M; Bakuła-Zalewska E; Koperski Ł; Wiechno W; Jażdżewski K
    PLoS One; 2016; 11(3):e0151968. PubMed ID: 27011326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma.
    Schwertheim S; Sheu SY; Worm K; Grabellus F; Schmid KW
    Horm Metab Res; 2009 Jun; 41(6):475-81. PubMed ID: 19370508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-let-7e inhibits invasion and magration and regulates HMGB1 expression in papillary thyroid carcinoma.
    Ding C; Yu H; Shi C; Shi T; Qin H; Cui Y
    Biomed Pharmacother; 2019 Feb; 110():528-536. PubMed ID: 30530288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.